Clinical Trial Update: Additional Xiaflex® Treatment in Patients With Peyronie's Disease Recurrence, Worsening, or Incomplete Response [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating additional Xiaflex treatment in patients with Peyronie's Disease who have recurrence, worsening, or incomplete response…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peyronie Disease

Drugs mentioned

• XIAFLEX (Collagenase Clostridium histolyticum)

Snippet

Sponsor: Manhattan Medical Research Practice, PLLC | Conditions: Peyronie's Disease | Phase 4 | Status: UNKNOWN